Pharmaceutical

Tripartite MoU signed for mRNA production platform in Egypt

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

Feb 7, 2025 - 06:00
Tripartite MoU signed for mRNA production platform in Egypt
EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.
Read the original article

Tags:

Previous Article

Supernus wins FDA approval for Parkinson’s pump on fourth try

Next Article

USPTO grants patent to Vistagen’s neuropathic pain treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Eli Lilly to acquire Versanis in heated race for weight loss drugs

STAT+: Eli Lilly to acquire Versanis in heated race for...

Jul 14, 2023

Newron and Myung In Pharm sign agreement for evenamide development

Newron and Myung In Pharm sign agreement for evenamide ...

Jan 10, 2025

STAT+: White House touts efforts to stem cancer drug shortages

STAT+: White House touts efforts to stem cancer drug sh...

Sep 12, 2023